Navigation Links
VivoMetrics(R) Introduces Next Generation LifeShirt Prototype, a Smart Garment That Delivers Real-time Vital Signs Remotely to Healthcare Providers
Date:6/8/2009

New LifeShirt(R) to Address Data and Usability Gaps in Remote Patient Monitoring Market

VENTURA, Calif., June 8 /PRNewswire/ -- VivoMetrics, Inc., a leading innovator in remote patient monitoring (RPM), announced today the first complete prototype of their next generation LifeShirt for the remote monitoring of patients' vital signs by healthcare professionals. The new LifeShirt has significant advantages over currently available monitoring technologies, dramatically simplifying the way in which key vital sign data is collected and transmitted to remote care providers. The system also provides a more complete understanding of patient health status by continuously collecting and fusing multiple vital signs into a validated, actionable health index--helping transform healthcare through the practical realization of telemedicine.

The next generation LifeShirt incorporates cutting-edge sensor technology and wireless data transmission into a lightweight, comfortable "smart garment" that eliminates the need for patients to operate multiple, discrete monitoring devices at specific times or to manually transmit vital sign data to those remotely managing their care. The system will passively and continuously collect electrocardiogram (ECG), respiratory, and temperature data in context with posture and activity levels and automatically transmit that data via cellular networks or Bluetooth to their healthcare providers.

VivoMetrics' new LifeShirt will nearly eliminate patient involvement in their own vital sign monitoring, requiring the user to simply wear the garment.

Numerous studies confirm the potential of RPM initiatives to improve outcomes for patients with chronic diseases and reduce the net cost of their care. It is estimated that savings resulting from RPM will reach $200 billion over the next 25 years in the United States alone(1). However, an April 2009 report by Datamonitor notes that availabl
'/>"/>

SOURCE VivoMetrics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Quest Diagnostics Introduces First Commercial Laboratory Test for Identifying the H1N1 Swine Flu Virus
2. Perceptive Informatics Introduces Medical Imaging Methodology to Accelerate Development Decisions About Alzheimers Treatments
3. Siemens Introduces New Standard of Care for Breast Ultrasound
4. Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C
5. Thermo Fisher Scientific Introduces Breakthrough in RNA-Interference Technology
6. CeloNova BioSciences Introduces a New Class of Coronary Stent: The CATANIA(TM) Coronary Stent System with NanoThin Polyzene(R)-F
7. Wedgewood Introduces Refresh(TM) Exchange-Program: Free Exchange of Expired Veterinary Compounded Medications Solves Key Industry Problem
8. Caliper Life Sciences Introduces Drug Combination Services to Identify Synergistic Response of Compounds
9. Dr. Dello Russo Introduces the New EYE-Q Lasik
10. Quest Diagnostics Introduces ClariSure(TM) Test for Identifying Chromosome Abnormalities Associated With 85 Developmental Disorders in Children
11. Lupus Foundation of America Fosters the Next Generation of Lupus Researchers by Awarding Gina M. Finzi Memorial Student Summer Fellowships to Five Students

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...,, BASKINGRIDGE,N.J.,Nov.25/PRNewswire/--Reg...lopmentofantithromboticaptamerswithactivecontrolag...illbepresentingatthePiperJaffray21stAnnualHealthCa...r.Mazzo,spresentationwillbegivenat1:10pm(EST)onTue...,spipelinewithemphasisontheleaddevelopmentprogram,...
(Date:11/25/2009)...,, NEWYORK,Nov.25/PRNewswire/--Reportlinker....einitscatalogue: ,, UnitedStatesDentalDevicesM....reportlinker.com/p0158733/United-States-Dental-De...,, UnitedStatesDentalDevicesMarketAnalysisandFo...essentialsourceforin-depthinformationanddatarelati...
(Date:11/25/2009)...,, UNIONCITY,Calif.,Nov.25/PRNewswire-FirstC...ompanymanufacturingpoint-of-carebloodanalysissyste...fexecutiveofficer,willpresentatthe21stAnnualPiperJ...09at2:00p.m.ET.TheconferencewillbeheldattheNewYork..., Abaxisdevelops,manufacturesandmarketsportableblo...
Breaking Medicine Technology:Regado Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference on December 1, 2009 2Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 2Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 3Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 4Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 5Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 6Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 7Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 8Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 9Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 10Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 11Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 12Insmed CEO Resigns Due to Health Concerns 12633 1Insmed CEO Resigns Due to Health Concerns 12633 2Insmed CEO Resigns Due to Health Concerns 12633 3Teens as Cardiologists in Training 3A Program Swaps Backpacks for Stethoscopes 48958 1Teens as Cardiologists in Training 3A Program Swaps Backpacks for Stethoscopes 48958 2Teens as Cardiologists in Training 3A Program Swaps Backpacks for Stethoscopes 48958 3Teens as Cardiologists in Training 3A Program Swaps Backpacks for Stethoscopes 48958 4Drug May Stem Slide Into Alzheimers for Some 48955 1Drug May Stem Slide Into Alzheimers for Some 48955 2
...III study will evaluate effects of otelixizumab, a...n preservation of endogenous insulin ...il 9, 2008 /PRNewswire/ - Tolerx, Inc., a,biopharm...elopment of novel,therapies for immune-mediated di...rd the initiation of a Phase III study of otelixiz...
...LANTA, April 9, 2008 Dutch biotechnology,company ...on and the South,African Tuberculosis Vaccine Init...ology data from a Phase I Ad35 tuberculosis vaccin... the World" conference (Atlanta,Georgia, April 9 t...uth,Africa and launched in May 2007, is the second...
Other Medicine Technology:Tolerx Advancing Novel Type 1 Diabetes Agent into Phase III Clinical Trial Program Following End of Phase II FDA Meeting 2Tolerx Advancing Novel Type 1 Diabetes Agent into Phase III Clinical Trial Program Following End of Phase II FDA Meeting 3Tolerx Advancing Novel Type 1 Diabetes Agent into Phase III Clinical Trial Program Following End of Phase II FDA Meeting 4Aeras, Crucell and South African Tuberculosis Vaccine Initiative Announce Encouraging Preliminary Results of Tuberculosis Vaccine Clinical Trial in South Africa 2Aeras, Crucell and South African Tuberculosis Vaccine Initiative Announce Encouraging Preliminary Results of Tuberculosis Vaccine Clinical Trial in South Africa 3Aeras, Crucell and South African Tuberculosis Vaccine Initiative Announce Encouraging Preliminary Results of Tuberculosis Vaccine Clinical Trial in South Africa 4Aeras, Crucell and South African Tuberculosis Vaccine Initiative Announce Encouraging Preliminary Results of Tuberculosis Vaccine Clinical Trial in South Africa 5Aeras, Crucell and South African Tuberculosis Vaccine Initiative Announce Encouraging Preliminary Results of Tuberculosis Vaccine Clinical Trial in South Africa 6
(Date:11/26/2009)... more letters from the North Pole, Textsanta.net l... from Santa , North Pole,...l efficiencies at the North Pole Santa Claus has a...over the globe informed of his Christmas progress ...arch department have identified a large and growin...
(Date:11/26/2009)...search Triangle Dental (RTDental), a leading denta...announced the expansion of its services to include...ug Macmillan. , Durham...d to announce that Dr. Doug Macmillan, an experien...itional advanced training seminar. RTDental&rsquo...
(Date:11/26/2009)...nis & Ennis, P.A. is offering free nationwide ...smin birth control pills who have suffered a Deep ... Heart Attack or other related cardiac issues or h...free at 1-800-856-6405 or go to the firm’s w...n online case evaluation form. , ...
(Date:11/25/2009)...5/PRNewswire/--TheBartleHallConventionCenterwillte...c.9-10,whenKansasCityhoststhelatestinaseriesofmass...liniceventhasthepotentialtobethebiggestoneyet,beca...donweekdaysinsteadofoveraweekend,"SheriWood,execut...dentoftheNationalAssociationofFreeClinics(NAFC). ,...
(Date:11/25/2009)...v.25/PRNewswire/-SentinelleMedicalInc.,aleadingman...ftwareandCalgaryScientificInc.,aleadingproviderofs...ionofAegis(TM)Breast4DAdvancedVisualizationsoftwar...o-footprintWebclientbasedmedicalimagingofferingint...owsforzero-footprintaccess-requiringnosoftwaredown...
Breaking Medicine News(10 mins):Health News:Text Messages from Santa | Santa goes GREEN by going MOBILE for The March of Dimes 2Health News:Dr. Douglas Macmillan Now Providing LUMINEERS at Research Triangle Dental 2Health News:Ennis & Ennis, P.A. Announces Nationwide Free, Confidential, Consultations For Users Of Yaz And Yasmin Birth Control Pills 2Health News:Ennis & Ennis, P.A. Announces Nationwide Free, Confidential, Consultations For Users Of Yaz And Yasmin Birth Control Pills 3Health News:Kansas City Prepares for Largest Free Health Clinic 2Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 2Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 3
...army to find clues that may help to build therapie... Dr. Lynn Boyd, an associate professor of biology ...o find out what effect certain enzymes will have, ...y at Redstone Arsenal. While it is not known...
...y may have the potential to reverse impairments in...a first-of-its-kind study published in the Journal... the study was rich in flavanols, naturally-occurr...ucts. These results suggest this flavanol-rich...
...s the breakdown of a brain system that regulates a...a possible target for new drug therapies to help i... of American adults are overweight and around 30 p... The research provides new understanding of ...
... make people even more wary of using agricultural ... a common chemical weed killer could be the hidden...sease, at least those with certain genes that rend...from the University of Alabama,conducted an experi...
...al health conditions are potentially around the co... study. The findings, which were based on anal...d cells, appear online March 6 in the American Jou...t, M.D., Ph.D., professor of psychiatry in the UI ...
...mitted suicide in Assam in the last few months whi.../ as there is virtually no access to treatment. ...le who committed suicide in recent months. The sit...ent of the Assam Network of Positive People (ANPP)...
Other Medicine News:Health News:New Study Suggests Special Cocoa may Lead to Sustained Improvement in Blood Vessel Function 2Health News:New Study Suggests Special Cocoa may Lead to Sustained Improvement in Blood Vessel Function 3Health News:New Study Suggests Special Cocoa may Lead to Sustained Improvement in Blood Vessel Function 4Health News:Targeting SOCS-3 can Control Obesity 2Health News:Weed Killer Plays a Pivotal Role in Those With Genetic Vulnerability to Parkinson’ 2Health News:Blood Tests may Be Possible for Mental Health Conditions 2Health News:Assam Reports HIV Suicides, Treatment a Distant Dream 2
... is variably N-glycosylated. The variation account...tween 43 and 56 kDa. Insulin-like growth factor bi...inity but do not bind insulin. Of the six distinct...t this time, IGFBP-3 has been shown to be the majo...
...00 tests per year through automatic scheduling and...rocessing up to 4 assays on 4 plates simultaneousl... presentation of the results, are controlled by Wi...ube rack) and 256 (POS-ID Linear Rack) samples can...
Immunosimplicity® Is-ENA Screen Test Kit
IMMULITE 2000 IGFBP-3
Medicine Products: